EVP, Global Head of R, D Martin Mackay sold $570K of Alexion Pharmaceuticals, Inc.

Sold$569,858

$139.98Price

4,071Shares

−9%Stake

What ALXN did after the filing

Prices for ALXN after this filing aren't in yet.

Traded Fri, Feb 5. Filed Mon, Feb 8, 7:56 PM ET, after the close. Not investment advice.